In the TCGA-BLCA cohort, TTN, KMT2D, MUC16, PIK3CA, SYNE1, HMCN1, EP300, MACF1, FLG and ELF3 had higher mutation frequencies in NCOR1-MT patients. Here, MACF1 is linked to bladder transitional cell carcinoma.